• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全基因组 CRISPR 筛选在原代人 T 细胞中揭示了免疫功能的关键调节因子。

Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.

机构信息

Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, USA.

UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.

出版信息

Cell. 2018 Dec 13;175(7):1958-1971.e15. doi: 10.1016/j.cell.2018.10.024. Epub 2018 Nov 15.

DOI:10.1016/j.cell.2018.10.024
PMID:30449619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6689405/
Abstract

Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioritize novel targets for drug development and improve the design of genetically reprogrammed cell-based therapies. However, large-scale CRISPR screens have been challenging in primary human cells. We developed a new method, single guide RNA (sgRNA) lentiviral infection with Cas9 protein electroporation (SLICE), to identify regulators of stimulation responses in primary human T cells. Genome-wide loss-of-function screens identified essential T cell receptor signaling components and genes that negatively tune proliferation following stimulation. Targeted ablation of individual candidate genes characterized hits and identified perturbations that enhanced cancer cell killing. SLICE coupled with single-cell RNA sequencing (RNA-seq) revealed signature stimulation-response gene programs altered by key genetic perturbations. SLICE genome-wide screening was also adaptable to identify mediators of immunosuppression, revealing genes controlling responses to adenosine signaling. The SLICE platform enables unbiased discovery and characterization of functional gene targets in primary cells.

摘要

人类 T 细胞是免疫和癌症免疫疗法的核心效应器。基于 CRISPR 的 T 细胞功能研究可以为药物开发确定新的优先靶点,并改进基因重编程细胞治疗的设计。然而,在原代人细胞中进行大规模的 CRISPR 筛选具有挑战性。我们开发了一种新方法,即 Cas9 蛋白电穿孔的单指导 RNA(sgRNA)慢病毒感染(SLICE),以鉴定原代人 T 细胞刺激反应的调节因子。全基因组功能丧失筛选鉴定了关键的 T 细胞受体信号传导成分和基因,这些基因在刺激后负调控增殖。对单个候选基因的靶向消融鉴定了增强癌细胞杀伤的命中靶点和扰动。SLICE 与单细胞 RNA 测序(RNA-seq)相结合,揭示了受关键遗传扰动改变的特征性刺激反应基因程序。SLICE 全基因组筛选也适用于鉴定免疫抑制的介质,揭示控制腺苷信号反应的基因。SLICE 平台可用于在原代细胞中进行无偏发现和功能基因靶点的鉴定。

相似文献

1
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.全基因组 CRISPR 筛选在原代人 T 细胞中揭示了免疫功能的关键调节因子。
Cell. 2018 Dec 13;175(7):1958-1971.e15. doi: 10.1016/j.cell.2018.10.024. Epub 2018 Nov 15.
2
CRISPR activation and interference screens decode stimulation responses in primary human T cells.CRISPR 激活和干扰筛选解码原代人 T 细胞的刺激反应。
Science. 2022 Feb 4;375(6580):eabj4008. doi: 10.1126/science.abj4008.
3
Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.细胞间 CRISPR 筛选发现癌症免疫治疗靶点
Front Immunol. 2022 May 16;13:884561. doi: 10.3389/fimmu.2022.884561. eCollection 2022.
4
CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection.CRISPR/Cas9介导的基因敲除筛选以及通过全基因组测序进行的靶点鉴定揭示了小RNA病毒感染所需的宿主基因。
J Biol Chem. 2017 Jun 23;292(25):10664-10671. doi: 10.1074/jbc.M117.782425. Epub 2017 Apr 26.
5
Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.利用 GUIDE-seq 定义全基因组范围的 CRISPR-Cas 基因组编辑核酸酶活性。
Nat Protoc. 2021 Dec;16(12):5592-5615. doi: 10.1038/s41596-021-00626-x. Epub 2021 Nov 12.
6
Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.依赖于强力霉素的 CRISPR-Cas9 自我失活以时间调节靶标和非靶标编辑。
Mol Ther. 2020 Jan 8;28(1):29-41. doi: 10.1016/j.ymthe.2019.09.006. Epub 2019 Sep 12.
7
CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.用于功能基因组筛选和表型相关基因鉴定的基于CRISPR的慢病毒敲除文库
Methods Mol Biol. 2019;1961:343-357. doi: 10.1007/978-1-4939-9170-9_21.
8
Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.嵌合敲除靶向技术在细胞免疫疗法的基因组工程中的应用。
Cell. 2020 Apr 30;181(3):728-744.e21. doi: 10.1016/j.cell.2020.03.039. Epub 2020 Apr 16.
9
Genome-scale CRISPR pooled screens.全基因组规模的CRISPR混合筛选
Anal Biochem. 2017 Sep 1;532:95-99. doi: 10.1016/j.ab.2016.05.014. Epub 2016 Jun 1.
10
GUIDES: sgRNA design for loss-of-function screens.指南:用于功能缺失筛选的sgRNA设计
Nat Methods. 2017 Aug 31;14(9):831-832. doi: 10.1038/nmeth.4423.

引用本文的文献

1
CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome.用于T细胞的CRISPR工具:靶向基因组、表观基因组和转录组。
Trends Cancer. 2025 Aug 28. doi: 10.1016/j.trecan.2025.08.001.
2
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.全基因组CRISPR筛选确定增强CAR-NK细胞抗肿瘤效力的关键靶点。
Cancer Cell. 2025 Aug 18. doi: 10.1016/j.ccell.2025.07.021.
3
Genome Editing Breeding with CRISPR-Cas Nucleases, Base Editors, and Prime Editors.基于CRISPR-Cas核酸酶、碱基编辑器和引导编辑器的基因组编辑育种

本文引用的文献

1
Reprogramming human T cell function and specificity with non-viral genome targeting.利用非病毒基因组靶向技术重新编程人类 T 细胞的功能和特异性。
Nature. 2018 Jul;559(7714):405-409. doi: 10.1038/s41586-018-0326-5. Epub 2018 Jul 11.
2
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.TET2 缺失可增强 CD19 靶向 T 细胞的治疗效果。
Nature. 2018 Jun;558(7709):307-312. doi: 10.1038/s41586-018-0178-z. Epub 2018 May 30.
3
The molecular basis of JAK/STAT inhibition by SOCS1.SOCS1 抑制 JAK/STAT 的分子基础。
Animals (Basel). 2025 Jul 22;15(15):2161. doi: 10.3390/ani15152161.
4
Protocol for efficient CRISPR/AAV-mediated genome editing and erythroid differentiation of human hematopoietic stem and progenitor cells.高效CRISPR/AAV介导的人类造血干细胞和祖细胞基因组编辑及红系分化方案。
STAR Protoc. 2025 Aug 5;6(3):104018. doi: 10.1016/j.xpro.2025.104018.
5
Exploring UBASH3A: from immune regulation to autoimmune diseases.探索泛素相关蛋白3A(UBASH3A):从免疫调节到自身免疫性疾病
J Transl Med. 2025 Jul 24;23(1):822. doi: 10.1186/s12967-025-06760-4.
6
Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.异基因嵌合抗原受体工程化细胞疗法治疗复发难治性大B细胞淋巴瘤:一项系统评价和荟萃分析。
Front Immunol. 2025 Jul 8;16:1585556. doi: 10.3389/fimmu.2025.1585556. eCollection 2025.
7
Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer.针对非小细胞肺癌中表皮生长因子受体(EGFR)新抗原的诱导多能干细胞(iPSC)衍生T细胞的研发
Mol Ther Methods Clin Dev. 2025 Jun 18;33(3):101517. doi: 10.1016/j.omtm.2025.101517. eCollection 2025 Sep 11.
8
Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer.化学传感器受体是癌症中巨噬细胞功能的脂质检测调节因子。
Nat Immunol. 2025 Jul;26(7):1182-1197. doi: 10.1038/s41590-025-02191-x. Epub 2025 Jun 30.
9
Live-cell analyses with unsegmented images to study cancer cell response to modified T cell therapy.使用未分割图像进行活细胞分析,以研究癌细胞对改良T细胞疗法的反应。
bioRxiv. 2025 Jun 7:2025.06.04.657687. doi: 10.1101/2025.06.04.657687.
10
A genome-wide in vivo CRISPR screen identifies neuroprotective strategies in the mouse and human retina.全基因组体内CRISPR筛选确定了小鼠和人类视网膜中的神经保护策略。
bioRxiv. 2025 Mar 24:2025.03.22.644712. doi: 10.1101/2025.03.22.644712.
Nat Commun. 2018 Apr 19;9(1):1558. doi: 10.1038/s41467-018-04013-1.
4
Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation.全基因组 CRISPR 筛选鉴定 FAM49B 为肌动蛋白动力学和 T 细胞激活的关键调节因子。
Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4051-E4060. doi: 10.1073/pnas.1801340115. Epub 2018 Apr 9.
5
Integrating single-cell transcriptomic data across different conditions, technologies, and species.整合不同条件、技术和物种的单细胞转录组数据。
Nat Biotechnol. 2018 Jun;36(5):411-420. doi: 10.1038/nbt.4096. Epub 2018 Apr 2.
6
CAR T cell immunotherapy for human cancer.嵌合抗原受体 T 细胞免疫疗法治疗人类癌症。
Science. 2018 Mar 23;359(6382):1361-1365. doi: 10.1126/science.aar6711.
7
Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells.优化的 RNP 转染用于高效的 CRISPR/Cas9 介导的原代 T 细胞基因敲除。
J Exp Med. 2018 Mar 5;215(3):985-997. doi: 10.1084/jem.20171626. Epub 2018 Feb 7.
8
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.一种主要的染色质调节因子决定肿瘤细胞对T细胞介导杀伤的抗性。
Science. 2018 Feb 16;359(6377):770-775. doi: 10.1126/science.aao1710. Epub 2018 Jan 4.
9
Am I ready for CRISPR? A user's guide to genetic screens.我准备好使用 CRISPR 了吗?遗传筛选的用户指南。
Nat Rev Genet. 2018 Feb;19(2):67-80. doi: 10.1038/nrg.2017.97. Epub 2017 Dec 4.
10
The Reactome Pathway Knowledgebase.Reactome 通路知识库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655. doi: 10.1093/nar/gkx1132.